Literature DB >> 4049471

Analysis of 6-mercaptopurine in serum or plasma using high performance liquid chromatography.

C E Whalen, H Tamary, M Greenberg, A Zipursky, S J Soldin.   

Abstract

The analysis of 6-mercaptopurine (6-MP) by a rapid, sensitive, and specific high performance liquid chromatographic assay is described. This method does not require any derivatization and allows for direct quantitation of the drug. Only 200 microliters of serum or plasma is needed, and concentrations as low as 10 ng/ml can be reliably quantitated. Analytical recoveries of 83% for 6-MP and 71% for the internal standard, 6-thioguanine, are obtained. Between-day precision studies at three plasma concentrations of 6-MP produce a mean coefficient of variation of 7.2%. This assay will be clinically useful for pharmacokinetic studies of 6-MP in patients in remission of acute lymphoblastic leukemia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4049471     DOI: 10.1097/00007691-198507030-00015

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  3 in total

1.  Detection of inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase by thioinosinic acid and azathioprine by a new colorimetric assay.

Authors:  T Ha; S L Morgan; W H Vaughn; I Eto; J E Baggott
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

2.  Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexate.

Authors:  F Innocenti; R Danesi; A Di Paolo; B Loru; C Favre; M Nardi; G Bocci; D Nardini; P Macchia; M Del Tacca
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

3.  Azathioprine toxicity, 6-mercaptopurine accumulation and the "poor" 6-thiopurine methylator phenotype.

Authors:  A Escousse; G Rifle; C Sgro; C Mousson; G Zanetta; D Chevet
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.